Country presentation UGANDA DR S ZARAMBA DIRECTOR GENERAL HEALTH SERVICES LANCASTER HOUSE, LONDON 16TH MAY 2008 04/06/09

MeTA ARRANGEMENTS IN UGANDA National coordination to be done by existing Medicines & Supplies Technical working Group Activity management to be done by a sub group of the TWG – key partners e.g. Government, CSO, Academia, WHO and private sector Secretariat to be the Pharmacy Division in the Ministry of Health Funds held in Partnership account-(jointly managed by government & partners) 04/06/09

National coordination to be done by existing Medicines & Supplies Technical working Group

Activity management to be done by a sub group of the TWG – key partners e.g. Government, CSO, Academia, WHO and private sector

Secretariat to be the Pharmacy Division in the Ministry of Health

Funds held in Partnership account-(jointly managed by government & partners)

TRANSPARENCY & ACCOUNTABILITY Commitment to transparency of information through a dedicated website, print and electronic media, and by other means. Content to be determined by work plan and activities 04/06/09

Commitment to transparency of information through a dedicated website, print and electronic media, and by other means.

Content to be determined by work plan and activities

STATUS OF MeTA WORK PLAN Work plan to be developed in consultation with agreed structures & stakeholders MeTA Secretariat visit requested as soon as possible Proposal to be submitted to the International Secretariat by end of July 2008 National launch possibly July 2008 04/06/09

Work plan to be developed in consultation with agreed structures & stakeholders

MeTA Secretariat visit requested as soon as possible

Proposal to be submitted to the International Secretariat by end of July 2008

National launch possibly July 2008

KEY ISSUES FOR MeTA IN UGANDA Sub-optimal availability of essential medicines High prices in retail outlets and dispensing Doctors Mistrust of quality of generics by the public Low level of consumer empowerment 04/06/09

Sub-optimal availability of essential medicines

High prices in retail outlets and dispensing Doctors

Mistrust of quality of generics by the public

Low level of consumer empowerment

SOME PLANNED ACTIVITIES Monitoring of prices & availability continues Monitoring quality - reassurance for the public on generics Interventions to improve availability in health facilities Interventions to improve rational use of medicines - prescribers & consumers 04/06/09

Monitoring of prices & availability continues

Monitoring quality - reassurance for the public on generics

Interventions to improve availability in health facilities

Interventions to improve rational use of medicines - prescribers & consumers

NATIONAL RESEARCH NEEDS Baseline studies to identify gaps for research & interventions 04/06/09

Baseline studies to identify gaps for research & interventions

SUPPORT NEEDS Capacity building for civil society Technical support to the country group – such as website design, quality of information to be shared, advocacy / use of media Regional & International linkages / learning 04/06/09

Capacity building for civil society

Technical support to the country group – such as website design, quality of information to be shared, advocacy / use of media

Regional & International linkages / learning

LESSONS LEARNED Experience of DFID funded multi-stakeholder Collaboration Project on medicines (GOV-CSO-WHO), provides a firm foundation for MeTA. 06/04/09

Experience of DFID funded multi-stakeholder Collaboration Project on medicines (GOV-CSO-WHO), provides a firm foundation for MeTA.